Open access · CC-BY
via OpenAlex
6-PPD quinone induces lifespan reduction by causing immunosuppression via DAF-16/PMK-1 signaling in Caenorhabditis elegans
Chengjie Shu, Wei Wang, Shengqi Cao, Beiwei Hou, Shunlin Gu, Lei Fu, Fenglun Zhang, Dayong Wang
Environmental Chemistry and Ecotoxicology · 2026 · ▲ 4 citations
Abstract
In Caenorhabditis elegans , suppression in innate immunity could be induced by 6-PPD quinone (6-PPDQ); however, underlying mechanism remains unknown. RNA interference (RNAi) of antimicrobial genes ( lys-7 and spp-1 ) enhanced 6-PPDQ-induced lifespan reduction and increased 6-PPDQ accumulation. Accompanied with these, expressions of daf-16 encoding FOXO transcriptional factor and pmk-1 encoding p38 MAPK were decreased by 6-PPDQ exposure. In 6-PPDQ exposed nematodes, daf-16 and pmk-1 RNAi caused more severe inhibition in expression of antimicrobial genes. Additionally, 6-PPDQ caused lifespan reduction and 6-PPDQ accumulation were accelerated by daf-16 and pmk-1 RNAi. 6-PPDQ induced decrease in expression of antimicrobial genes and lifespan reduction and 6-PPDQ accumulation could be suppressed by pharmacological treatment with cuminaldehyde. Moreover, these beneficial effects of cuminaldehyde treatment were inhibited by daf-16 and pmk-1 RNAi, which further suggests crucial functions of DAF-16 and PMK-1. Our results highlight association of immunosuppression with 6-PPDQ-induced lifespan reduction, which was controlled by molecular signals of DAF-16 and PMK-1. • lys-7 and spp-1 RNAi enhanced 6-PPDQ induced lifespan reduction and 6-PPDQ accumulation. • 6-PPDQ induced immunosuppression was strengthened by RNAi of daf-16 and pmk-1. • daf-16 and pmk-1 RNAi accelerated 6-PPDQ caused lifespan reduction and 6-PPDQ accumulation. • Beneficial effect of cuminaldehyde against 6-PPDQ toxicity was inhibited by daf-16 and pmk-1 RNAi.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.enceco.2026.01.029
- Canonical
- link ↗
- Fetched
- 2026-06-30 MST
Cite this
APA
Shu, C., Wang, W., Cao, S., Hou, B., Gu, S., Fu, L., Zhang, F., & Wang, D. (2026). 6-PPD quinone induces lifespan reduction by causing immunosuppression via DAF-16/PMK-1 signaling in Caenorhabditis elegans. <em>Environmental Chemistry and Ecotoxicology</em>. https://doi.org/10.1016/j.enceco.2026.01.029
Vancouver
Shu C, Wang W, Cao S, Hou B, Gu S, Fu L, et al. 6-PPD quinone induces lifespan reduction by causing immunosuppression via DAF-16/PMK-1 signaling in Caenorhabditis elegans. Environmental Chemistry and Ecotoxicology. 2026. doi:10.1016/j.enceco.2026.01.029.
BibTeX
@article{chengjie2026PPDqui,
title = {6-PPD quinone induces lifespan reduction by causing immunosuppression via DAF-16/PMK-1 signaling in Caenorhabditis elegans},
author = {Chengjie Shu and Wei Wang and Shengqi Cao and Beiwei Hou and Shunlin Gu and Lei Fu and Fenglun Zhang and Dayong Wang},
journal = {Environmental Chemistry and Ecotoxicology},
year = {2026},
doi = {10.1016/j.enceco.2026.01.029},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2023
Open access · CC-BY
Paeoniflorin mitigates high glucose-induced lifespan reduction by inhibiting insulin signaling in Caenorhabditis elegans
Oxidative Medicine and Cellular Longevity 2019
Open access · CC-BY
Carnosol Improved Lifespan and Healthspan by Promoting Antioxidant Capacity in <i>Caenorhabditis elegans</i>
The FASEB Journal 2008
Citation only
Inhibition of a eukaryotic initiation factor ( <i>eIF2Bδ</i> ,/F11A3.2) during adulthood extends lifespan in <i>Caenorhabditis elegans</i>
Archives of gerontology and geriatrics 2026
Citation only
Dendrobium nobile Lindl. Alkaloids promote longevity and stress resistance of Caenorhabditis elegans via DAF-16 and skn-1.
Journal of Agricultural and Food Chemistry 2014
Citation only
Mechanism of Longevity Extension of<i>Caenorhabditis elegans</i>Induced by Pentagalloyl Glucose Isolated from Eucalyptus Leaves
BMC complementary medicine and therapies 2025
Open access · OA